Drug recall D-1502-2016

Class III Terminated reported Sep 28, 2016

Product

Lisinopril Tablets USP, 30 mg, packaged in a) 500-count bottles (NDC 68180-516-02) and b) 100-count bottles (NDC 68180-516-01); Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, United States; Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, INDIA.

Reason for recall

CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.

Lots and codes

Batch number: H303487, H303488, H303489, Exp 09/16

Recall details

Recalling firm
Lupin Pharmaceuticals Inc., Baltimore, MD
Quantity
20,556 bottles
Distribution
All product distributed domestically in the US. No recalled product was distributed to U.S. Government Agency consignees directly by Lupin. No recalled product was distributed to any foreign consignees by Lupin.
Type
Voluntary: Firm initiated
Recall initiated
April 6, 2016
Terminated
August 7, 2017

Related products